Company Filing History:
Years Active: 2014-2023
Title: Katja Kroll: Innovator in Antibody Technology
Introduction
Katja Kroll is a prominent inventor based in Frankfurt-am-Main, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of multispecific antibodies. With a total of four patents to her name, her work is paving the way for advancements in cancer treatment.
Latest Patents
Kroll's latest patents include innovative technologies such as multispecific antibodies that facilitate selective light chain pairing. These antibodies are designed to ensure that the desired chain pairing occurs, utilizing different dimerization domains for effective light chain pairing. Additionally, her patents cover anti-CD3 antibodies and anti-CD123 antibodies, which are crucial for targeting specific antigens in cancer therapies. The inventions also encompass pharmaceutical compositions that utilize these antibodies, along with methods for isolating them.
Career Highlights
Katja Kroll is currently employed at Sanofi, a leading global healthcare company. Her work at Sanofi focuses on the development of novel therapeutic solutions that leverage her expertise in antibody technology. Kroll's innovative approach has positioned her as a key player in the biotechnology sector.
Collaborations
Throughout her career, Kroll has collaborated with notable colleagues such as Christian Lange and Ercole Rao. These partnerships have further enhanced her research and development efforts, contributing to the success of her innovative projects.
Conclusion
Katja Kroll's contributions to antibody technology and her commitment to advancing cancer treatment exemplify her role as a leading inventor in the biotechnology field. Her work continues to inspire future innovations in medical science.